More evidence Russia’s Ministry of Health (MoH) may be getting better at approving trials emerged this week - at least when it comes to international studies.
Sponsors want CROs to join the debate on quality management in clinical research says the Avoca Group, which has invited contractors to sign up to its recently established industry consortium.
Sigma-Aldrich says it is a step closer to becoming a one-stop-shop for biopharmas in the drug discovery process after it inked a takeover agreement with biological testing firm BioReliance.
A prior relationship rather than price was the most significant factor in helping Icon win its strategic deal with Shire according to an analyst who says such a trend is good for the sector.
New Asian CRO Alliance (ACA) can offer faster and better decision making than multinational CROs says Semler Research Centre's clinical development VP.
Charles River Laboratories’ (CRL) preclinical division will continue to struggle in 2012 but the recent uptick in strategic partnership activity is a ray of hope according to a leading analyst.
Ireland-based CRO Icon says acquisition of Chinese trial firm BeijingWits Medical Consulting will boost capabilities in the country and help meet growing demand from global clients.
The requirement for local clinical trials has been a ‘serious blow’ to Russia’s drug approval system and an opportunity for unethical CROs according to the Moscow-based Association of Clinical Trial Organisations (ACTO).
The CRO industry is still considered a good long-term investment and the clinical services segment is set to continue its dominance thanks to sponsor R&D spending, says leading banker.
Twelve of the top 20 Big Pharmas could soon outsource 100 per cent of their clinical trial work using one of two strategic partnering models according to a speaker at contract research industry conference in Lyon, France yesterday.
Drug giant GlaxoSmithKline (GSK), contract research organisation (CRO) Medpace, and institutional review board Quorum Review IRB have all been honoured with Eagle awards at this year's Site Solutions Summit, held in Ellicott City, Maryland, USA.
Quintiles has bought its way into the observational research space with the acquisition of Outcome Sciences and strengthened its market access standing with the purchase of VCG & Associates.
Outsourcing-pharma.com presents a roundup of deals in the contract research space with acquisitions by Aptiv and Eurofins, another partnership for Spaulding and fundraising by Clinipace.
Kellman Pharmaceutical Services (KPS) and trial management services firm Y-Prime have put pen to paper in a deal to develop a series of clinical electronic monitor visit reporting (e-MVR) tools.
Medical Photography is a potentially valuable yet underused resource in clinical trials according to Illingworth Research, which aims to increase its exposure with a new service.
Mid-tier CROs are being squeezed out of the post-marketing sector as sponsors choose providers with more scale or specialisation, market research found.
Preclinical CRO Porsolt has opened a new research centre and laboratory space citing industry demand for large scale studies as the key driver for the investment.
